Clinical Trials
9
Active:0
Completed:4
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
Not Applicable
- Conditions
- Acute Heart FailureSevere Sepsis
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Mespere Lifesciences Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT02258984
- Locations
- 🇺🇸
Detroit Receiving Hospital, Detroit, Michigan, United States
ED Decision Making Among Hypotensive Patients
- Conditions
- Hypotension
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Mespere Lifesciences Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT02221908
- Locations
- 🇺🇸
Hahnemann Hospital, Philadelphia, Pennsylvania, United States
Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions
- Conditions
- ADHF
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Mespere Lifesciences Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT02003040
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
Correlation of Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter
Completed
- Conditions
- Validation of Oximeter System
- First Posted Date
- 2013-07-26
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Mespere Lifesciences Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT01908790
- Locations
- 🇺🇸
University of Michigan Cardiovascular Center, Ann Arbor, Michigan, United States
Comparison of Central Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter
- Conditions
- Post Cardiac Surgery Low Output Syndrome Requiring Inotropic/Vasopressor TherapySepsisCardiogenic Shock Post Myocardial InfarctionHypoxemic Respiratory Failure.
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Mespere Lifesciences Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01788956
- Locations
- 🇨🇦
London Health Sciences Center, University Hospital, London, Ontario, Canada
- Prev
- 1
- 2
- Next
News
No news found